Press Release: European Medicines Agency advises of risk of fever in young children following vaccination with Pandemrix

The European Medicines Agency (EMEA), on 4 December 2009, warned that young children may experience fever after their second dose of the pandemic influenza vaccine Pandemrix. The Agency recommended that this information be included in the prescribing information, and be taken into consideration when deciding whether to give a second dose to children.